How does pcp work

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 17, 2026

Quick Answer: Phencyclidine (PCP) is a dissociative anesthetic that disrupts glutamate signaling in the brain by blocking NMDA receptors. It was developed in the 1950s but withdrawn by 1965 due to severe psychological side effects.

Key Facts

PCP was first synthesized in 1956 by Parke-Davis as an intravenous anesthetic.
It was discontinued for human use by 1965 due to high incidence of hallucinations and psychosis.
PCP binds to NMDA receptors, blocking glutamate and causing dissociative effects.
At low doses (1–5 mg), PCP causes euphoria; at higher doses, it can induce seizures and coma.
In 2020, approximately 0.3% of U.S. adults reported using hallucinogens like PCP in the past year.

Overview

Phencyclidine, commonly known as PCP, is a synthetic dissociative drug originally developed for medical use. It was introduced in the 1950s as a surgical anesthetic but was quickly abandoned due to severe adverse reactions.

Today, PCP is primarily used illicitly and is classified as a Schedule II controlled substance in the United States. Its effects range from mild euphoria to extreme agitation, hallucinations, and violent behavior.

Synthesized in 1956: Chemist H. David Dahlberg first created PCP at Parke-Davis to develop a safer alternative to existing anesthetics.
Marketed as Sernyl: The drug was briefly used in humans under this name before being withdrawn due to unpredictable psychological effects.
Withdrawn by 1965: Clinical trials showed that up to 50% of patients experienced delirium, hallucinations, or psychosis after administration.
Illicit use surged in the 1970s: PCP became popular on the streets under names like angel dust, often smoked or ingested in powder form.
Current status: It remains a drug of abuse, with occasional use reported in urban areas despite its dangerous side effect profile.

How It Works

PCP exerts its effects primarily through interference with neurotransmitter systems in the brain, especially glutamate signaling.

NMDA Receptor Antagonism: PCP blocks NMDA-type glutamate receptors, disrupting normal synaptic transmission and leading to dissociative anesthesia in 1–5 mg doses.
Dopamine Reuptake Inhibition: It increases dopamine levels in the brain’s reward pathway, contributing to euphoria and potential for addiction.
Sigma Receptor Activation: PCP binds to sigma receptors, which may explain its hallucinogenic and psychotomimetic effects at higher concentrations.
Altered Sensory Perception: By disrupting cortical integration, users report feeling detached from their body, a state known as dissociation.
Duration and Metabolism: Effects last 4–6 hours when smoked; the liver metabolizes PCP into active compounds that can prolong symptoms.
Neurotoxic Potential: Chronic use has been linked to long-term cognitive deficits, including memory loss and speech difficulties.

Comparison at a Glance

Below is a comparison of PCP with other dissociative and hallucinogenic drugs based on mechanism, potency, and risk profile.

Drug	Mechanism	Onset	Duration	Primary Risks
PCP	NMDA receptor antagonist	1–5 minutes (smoked)	4–6 hours	Psychosis, aggression, seizures
Ketamine	NMDA receptor antagonist	1–2 minutes (IV)	30–60 minutes	Dissociation, bladder damage
LSD	Serotonin 5-HT2A agonist	20–40 minutes	8–12 hours	Anxiety, hallucinations
DXM	NMDA antagonist, sigma agonist	15–30 minutes	3–6 hours	Nausea, confusion
Salvia	Kappa opioid agonist	Under 1 minute	5–15 minutes	Disorientation, loss of coordination

This table illustrates that while PCP shares mechanisms with drugs like ketamine and DXM, its longer duration and higher risk of violent behavior make it particularly dangerous. Unlike LSD, which primarily affects serotonin, PCP’s glutamate disruption leads to more profound dissociation and neurological instability.

Why It Matters

Understanding how PCP works is essential for public health, emergency medicine, and addiction treatment. Despite declining use, it remains a concern due to its potent and unpredictable effects.

Emergency room challenges: PCP intoxication can mimic schizophrenia, making diagnosis difficult without a patient history.
Violent episodes: Cases of extreme aggression linked to PCP have led to law enforcement being involved in medical emergencies.
Long-term cognitive effects: Chronic users may suffer from memory impairment and reduced attention span even after cessation.
Drug interactions: PCP combined with depressants like alcohol increases the risk of respiratory depression and coma.
Treatment limitations: No specific antidote exists; management is primarily supportive and symptom-based.
Legal implications: Possession of PCP carries federal penalties, reflecting its classification as a high-risk substance.

While PCP is no longer used medically, its neurochemical profile continues to inform research on anesthesia and psychiatric disorders. However, its dangers far outweigh any potential benefits, reinforcing the need for public awareness and prevention.